Clinical Trials Logo

Clinical Trial Summary

In this randomized, placebo controlled, double blind trial, effects of relatively high doses of chicken protein hydrolysate (CPH) or casein hydrolysate (placebo) supplementation will be investigate in healthy persons with abdominal obesity. The 12-week study examines potential effects on body weight, abdominal obesity, body composition, plasma parameters of metabolic health including lipids, inflammatory parameters, redox state and microbiota biomarkers.


Clinical Trial Description

Small peptides in the range of 2 - 12 amino acids are believed to cross the intestinal wall undigested and enter the circulation where they can have a range of activities based on their amino acid composition and structure. Natural peptides isolated from a number of food proteins, including plants and marine organisms, are shown to have antioxidant effects in in vitro tests, and anti-hypertensive effects in mice through inhibition of the angiotensin-converting-enzyme (ACE). Protein hydrolysates from both animal- and plant-based sources will consist of a mixture of potentially bioactive peptides that can have specific effects based on their composition. Studies have shown that egg- and soy-derived hydrolysates have anti-diabetic and anti-obesity properties in rodents. Pre-clinical studies in mice have demonstrated potent plasma cytokine lowering abilities and atherosclerosis-prevention by chicken protein hydrolysate (CPH) diets, as well as effects on plasma cholesterol level, cytokines and lipid metabolism, including mitochondrial function. In addition, an isolated peptide fraction from chicken inhibits the dipeptyl peptidase IV, and thus has the potential to restore glucose homeostasis in type 2 diabetics. The hydrolysate supplements used in this study are obtained from rest raw materials (RRM) from mechanical deboning of chicken meat (Food Grade, Nortura AS Hærland, Norway). Freshly minced chicken RRM has been treated with enzymes optimized to generate bioactive hydrolysates. The supplement is given in a dose of 18 g protein per day, corresponding to the protein content of a standard meal, and similar to doses recommended in protein shake supplements. Around 60 males and females age >20 years with abdominal obesity participate, recruited primarily through social media advertisements (Facebook) limited to a 12 km radius around the city center of Bergen. Participants provided written informed consent, and were screened via self-reporting in an online form in EasyTrial hosted by the Research Unit for Clinical Trials at the University of Bergen. Data collection by the study staff at baseline verifies inclusion and exclusion criteria and participant eligibility prior to randomization. The potential participants are informed about practical details at a digital or physical meeting 1-2 weeks prior to baseline. Groups of participants (40-60% males/females) are block randomized to the two treatments (CPH or placebo casein supplementation) using randomly selected block sizes, and stratified according to sex. The participants are given a container with the powder sufficient for the entire 12-week study period, and a spoon to measure the intake at breakfast (6 g), lunch (6 g) and supper (6 g), or morning (9 g) and evening (9 g) according to individual preference. The patients will mix the powder products in water or mineral water. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05149092
Study type Interventional
Source University of Bergen
Contact
Status Completed
Phase N/A
Start date January 18, 2021
Completion date April 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04940962 - Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion N/A
Completed NCT02194504 - The Belly Fat Study: Nutritional Intervention to Improve Metabolic Health in Subjects With Increased Abdominal Adiposity N/A
Completed NCT00374218 - Effect of Replacing HFCS With Sucromalt in Subjects With Raised Waist Circumference Phase 2
Completed NCT00520858 - Effects of Exercise Modality on Abdominal Obesity and Health Risk Factors in Older Men and Women N/A
Recruiting NCT03212391 - WAVE Study- Walking and Aging in VErona Study N/A
Completed NCT03898518 - The Effects of a Jump Rope Exercise Program on Body Composition and Self-efficacy in Obese Adolescent Girls N/A
Recruiting NCT04136717 - Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery N/A
Completed NCT05413954 - To Evaluate the Health Effect of Particular Fatty Acids Profiles From Eggs N/A
Recruiting NCT05062954 - Effects of a Polyphenol-rich Cranberry Extract on Cardiometabolic and Neurocognitive Health N/A
Completed NCT01472666 - Dairy Lipids, Proteins, and the Metabolic Syndrome - "DairyHealth" N/A
Completed NCT00990457 - Evaluating the Effects Two Diets Combined With Exercise in Persons With Abdominal Obesity (The SHAPE5 Study) Phase 3
Completed NCT05685017 - Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents
Completed NCT03773900 - Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers N/A
Completed NCT04635332 - Food Literacy and Physical Activity Intervention to Optimize Metabolic Health Among Women in Urban Uganda N/A
Completed NCT00739180 - Physical Activity in Youth: Implications for Reversing Risk Factors for Type 2 Diabetes N/A
Completed NCT00664729 - Diet, Exercise, Metabolism, and Obesity in Older Women N/A
Completed NCT03389425 - Application of the SIMPLE Program for Weight Loss at Pathways to Housing: A Feasibility Study N/A
Completed NCT05900843 - Weight Abnormalities With Diet and Exercise Frequency in Egyptian Children With Cerebral Palsy
Not yet recruiting NCT06376955 - High Intensity Interval Versus Focused Ultrasound on Insulin Resistance in Diabetics With Abdominal Obesity N/A
Recruiting NCT05879692 - Response of Irritable Bowel Syndrome to Abdominal Fat Reduction N/A